Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
American Peptide Company
American Peptide signs manufacturing supply deal with Affymax
May 8th, 2006
American Peptide Company (APC) has entered into a manufacturing clinical supply agreement with Affymax, Inc., for the current Good Manufacturing Practices (cGMP) production of the Affymax drug candidate Hematide. A synthetic, peptide-based, next-generation erythropoiesis-stimulating agent (ESA), Hematide is designed to stimulate the production of red blood cells. It is being evaluated by Affymax in phase II clinical trials to treat anemia in patients with chronic kidney disease (CKD) and cancer. APC had previously successfully manufactured preclinical lots of Hematide for Affymax and will manufacture clinical supplies of Hematide at its large-scale...
Source: Biotech Week (2006-05-08)
|
